INT241778

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.10
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.32
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

response to stress (AVP, AVPR1A) signal transducer activity (AVP, AVPR1A) generation of precursor metabolites and energy (AVP, AVPR1A)
endosome (AVPR1A) transmembrane transport (AVP) cell-cell signaling (AVP)
Anatomy Link Frequency
cardiomyocyte 1
AVP (Homo sapiens)
AVPR1A (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 21 5.00 Very Low Very Low Very Low
anticonvulsant 2 5.00 Very Low Very Low Very Low
Neuropeptide 2 5.00 Very Low Very Low Very Low
tricyclic antidepressant 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Nicotine 1 5.00 Very Low Very Low Very Low
Bioavailability 1 5.00 Very Low Very Low Very Low
Versed 1 5.00 Very Low Very Low Very Low
medulla 1 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Increased Venous Pressure Under Development 5 100.00 Very High Very High Very High
Hypertrophy 1 100.00 Very High Very High Very High
Pressure And Volume Under Development 9 99.24 Very High Very High Very High
Heart Rate Under Development 24 96.72 Very High Very High Very High
Hyponatremia 62 91.76 High High
Myocardial Infarction 16 88.56 High High
Pressure Volume 2 Under Development 12 80.00 Quite High
Cirrhosis 9 68.96 Quite High
Nephrosis 2 67.92 Quite High
Cancer 1 10.40 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In cases of CHF, where the reduced cardiac function fails to effectively drive the blood volume from the venous to arterial circulation to maintain the effective arterial volume, AVP is upregulated to induce cardiomyocyte hypertrophy and vasoconstriction via V1A and enhance renal water retention via V2, as compensatory mechanisms to increase the effective arterial volume.
AVP Positive_regulation (induce) of V1A in cardiomyocyte associated with pressure and volume under development, hypertrophy, heart rate under development and increased venous pressure under development
1) Confidence 0.10 Published 2008 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2504060 Disease Relevance 1.32 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox